Year
Edition number
№3 / 2022
Передовая
Pokrovsky V.V.
It was in Elista (on the occasion of the 100th anniversary of sanitary and epidemiological service)6-11
Epidemic situation
Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G., Kirzhanova V.V.
Prevalence of human immune deficiency virus infection in the territories of the Russian Federation in 202112-18
Avksentiev N.A., Makarov A.S., Makarova Yu.V., Pazukhina E.M., Sisigina N.N., Feoktistova O.A. Zaitseva E.E., Kuznetsov S.D., Pace A., Saitkulov K.I.
The social and economic burdens of HIV in the Russian Federation19-25
Senkina E.L. Demchenko M.A.
The epidemic situation of HIV infection in the Ryazan Region over 2011–2020 and the impact of the COVID-19 pandemic on HIV incidence rates26-30
Lapovok I.A., Kirichenko A.A., Shlykova A.V., Saleeva D.V., Lopatukhin A.E., Kireev D.E., Ladnaia N.N., Musabaev E.I., Kazakova E.I., Ibadullaeva N.S., Ibragimova S.S., Safarova A.M., Kadirova A., Nurlyaminova Z., Ismatova L., Zukhurova M., Kholnazarov R., Bekbolotov A.A., Narmatova E.B., Iskanova B.M., Grigoryan T.R., Petrosyan A.R., Sargatyan T.A., Gasich E.L., Bunas A.S., Glinskaya I.N., Pokrovsky V.V.
Molecular epidemiological analysis of HIV-1 genetic variants circulating in the countries of Eastern European and Central Asia in 2010-201931-40
Original investigations
Pokrovskaya A.V., Barsky K.A., Korenev D.A., Petrov A.S., Kalinin A.A., Pchelin I.V., Popova A.A.
Behavioral risks for HIV infection in men who have sex with men (according to the survey results)41-45
Popova A.A., Domonova E.A., Goloveshkina E.N., Gromova A.V., Makhova T.I., Petrov A.S., Korenev D.A., Barsky K.A., Pokrovskaya A.V.
Screening for STI pathogens in vulnerable groups outside of healthcaare facilities: anal canal self-swabbing46-53
Kuimova U.A., Belyaeva V.V., Kozyrina N.V., Kulabukhova E.I., Goliusova M.D., Kuimova I.V.
Assessment of awareness of pre-exposure prophylaxis methods against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers54-58
Kanestri V.G., Kuimova U.A., Goliusova M.D.
Comparative analysis of clinical and laboratory outcomes in HIV-infected patients vaccinated and not vaccinated against COVID-1959-64
Belyaeva V.V., Sokolova E.V., Kozyrina N.V., Kuimova V.A., Kulabukhova E.I., Goliusova M.D.
Memory status and self-assessment of asthenia in HIV-infected patients receiving antiretroviral therapy65-70
Kulabukhova E.I., Kravchenko A.V., Zimina V.N., Pokrovskaya A.V., Suvorova Z.K., Khokhlova O.N., Vinokurova O.O., Kadyrova A.A., Rzaeva A.M., Sarkisyants N.K., Davidyan A.S., Sergeenko S.V., Saprykina Zh.A., Bekbolotov A.A., Abdrakhmanova E.D., Volchenkov G.V., Zamkovaya T.N.., Sattorov S.S., Soliev A.A., Bekmetova M.Yu., Normuratova G.A., Pokrovsky V.V.
Risk factors for tuberculosis in patients with HIV infection71-77
Reviews and lectures
Ermak T.N.
History of Peruvian wart and its relatives78-83
Exchange of experience
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Goliusova M.D., Kulabukhova E.I., Kanestri V.G., Kozyrina N.V., Mityurina E.V.
The efficiency and safety of ART after switching patients to the combined Russian NRTI phosphaladine in combination with elsulfavirine84-90
Leneva I.A., Gracheva A.V., Korchevaya E.R., Smirnova D.I., Faizuloev E.V.
Experimental study of the effect of the active substance of miramistin® on the infectious activity of SARS-CoV-2 in vitro91-96
